Chlorambucil Plus Theophylline vs Chlorambucil Alone as a Front Line Therapy for B-Cell Chronic Lymphatic Leukemia

References

• Galton, D.A.G., Wiltshaw, E., Szu, R.L. and Dacie, J.V. (1961) "The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukemia", Br. J. HaematoL, 7, 73–98.
   Web of Science ®Google Scholar
• Foon, K.A. and Gale, R.P. (1987) "Staging and therapy of chronic lymphocytic leukemia", Semin. Hematol., 24, 264–274.
   Web of Science ®Google Scholar
• Begleiter, A., Mowat, M., Israels, L.G. and Johnston, J.B. (1996) "Chlorambucil in chronic lymphocytic leukemia—Mechanism of action", Leuk. Lymph., 23, 187–201.
   PubMed Web of Science ®Google Scholar
• Sawitsky, A., Rai, KR., Glidewell, O., Silver, R.T. and participat-ing members of CALGB (Cancer and Leukemia Group B). (1977) "Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia", Blood, 50, 1049–1059.
   PubMed Web of Science ®Google Scholar
• Knospe, W.H., Loeb, V. and Huguley, C.M. (1974) "Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia", Cancer, 33, 555 — 562.
   Google Scholar
• Han, T., Ezdinli, E.Z., Shimaoka, K. and Desai, D.V. (1973) "Chlorambucil vs combined chlorambucil-corticosteroids in chronic lymphocytic leukemia", Cancer, 31, 502 — 508.
   Google Scholar
• Jaksic, B. and Brugiatelli, M. (1988) "High dose continuous chlormabucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL. IGCI CLL-01 trial", Nouv. Rev. Fr. Hematol., 30, 437–442.
   Google Scholar
• Mentz, F., Mossalayi, M.D., Ouaaz, F., Baudet, S., Issaly, F., Ktorza, S., et al. (1996) "Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells", Blood, 88, 2172–2182.
   Google Scholar
• Cheson, B.D., Bennett, J.M., Rai, KR., Greyer, MR., Kay, N.E., Oken, MM., et al. (1989) "Chronic lymphocytic leukemia: recommendations", Ann. Intern. Med., 110, 664–665.
   Web of Science ®Google Scholar
• Rai, KR., Savisky, A., Cronlcile, E.P., Chanana, A.D., Levy, R. and Paslermack, B.S. (1975) "Clinical staging of chronic lympho-cytic leukemia", Blood, 46, 219–234.
   Google Scholar
• Cheson, B.D., Bennett, J.M., Greyer, M., Kay, N., Keating, Mi., Obrien, S., et al. (1996) "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment", Blood, 87, 4990–4997.
   Google Scholar
• World Health Organization (1979) WHO Handbook for reporting Results of Cancer Treatment. Geneva: WHO Offset Publications.
   Google Scholar
• Kaplan, E. and Meier, P. (1958) "Non parametric estimation from incomplete observations", J. Am. Stat. Assoc., 53, 457.
   Web of Science ®Google Scholar
• Reed, J.C. and Kitada, S. (2001) Apoptosis dysregulation in chronic lymphocytic leukemia. In Chronic Lymphoid Leukemias, edited by B.D. Cheson. Pp 111–126. New York: Marcel Dekker, Inc.
   Google Scholar
• Dighiero, G., Travade, P., Chevret, S., Fenawc, P., Chastang, C. and Binet, J.I. (1991) "B-cell chronic lymphocytic leukemia: present status and future directions", Blood, 78, 1901–1914.
   Google Scholar
• O'Brien, S., Del Giglio, A. and Keating, M. (1995) "Advances in the biology and treatment of B-cell chronic lymphocytic leukemia", Blood, 85, 307 — 318.
   Google Scholar
• Caligaris-Cappio, F. (1996) "B-chronic lymphocytic leukemia: a malignancy of anti- self B cells", Blood, 87, 2615–2620.
   Google Scholar
• Kipps, T. (1997) "Chronic lymphocytic leukemia", Curr. Opin. Hematol., 4, 268–276.
   PubMedGoogle Scholar
• Jewell, A.P. (2002) "Role of apoptosis in the pathogenesis of B-cell chronic lymphocytic leukemia", Br. J. Biomed. Sci., 59, 235–238.
   Google Scholar
• Pepper, C., Hooper, K., Thomas, A., Hoy, T. and Bentley, P. (2001) "BcL-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukemia cells", Leuk. Lymphoma, 42, 491 — 498.
   PubMed Web of Science ®Google Scholar
• Begleiter, A., Lee, K., Israels, I.G., Mowat, M.R. and Johnston, J.B. (1994) "Chlorambucil induced apoptosis in chronic lymphocy-tic leukemia (CLL) and its relationship to clinical efficiency", Leuk. Lymphoma, 8, 103, suppl 1.
   Google Scholar
• Mentz, F., Merle-Beral, H., Ouaaz, F. and Binet, J.L. (1995) "Theophylline, a new inducer of apoptosis in B-CLL: role of cyclic nucleotides", Br. J. HaematoL, 90, 957–959.
   Web of Science ®Google Scholar
• Mentz, F., Merle-Beral, H. and Dalloul, A.H. (1999) "Theophyl-line-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production", Leukemia, 13, 78–84.
   PubMed Web of Science ®Google Scholar
• Kebabian, J.W. (1992) "The cyclic AMP cascade: A signal transduction system", Neurotransmissions, 2, 1.
   PubMedGoogle Scholar
• Lee, R., Wolda, S., Moon, E., Esselstyn, J., Hertel, C. and Lerner, A. (2002) "PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP", Cell Signal, 14, 277 — 284.
   Google Scholar
• McConkey, DJ., Aguilar-Santelises, M., Hartzell, P., Eriksson, I., Mellstedt, H., Orrenius, S., et al. (1991) "Induction of DNA fragmentation in chronic B lymphocytic leukemia cells". J. Immunol., 146, 1072–1076.
   PubMed Web of Science ®Google Scholar
• Lalli, E. and Sasson-Corsi, P. (1994) "Signal transduction and gene regulation: The nuclear response to cAMP", J. Biol. Chem., 269, 17359 — 17362.
   Web of Science ®Google Scholar
• Rasmussen, H., Isales, C., Ganesan, S., Calle, R. and Zawalich, W. (1992) "Ca2 + cyclic AMP interactions in sustained cellular responses", Ciba Found Symp., 164, 98.
   Google Scholar
• Choi, E.J., Xia, Z., Villacres, E.C. and Storm, D.R. (1993) "The regulatory diversity of the mammalian adenyl cyclase", Curr. Opin. Cell. Biol., 5, 269–273.
   Web of Science ®Google Scholar
• Sachs, L. and Lotem, J. (1993) "Control of programmed cell death in normal and leukemic cells: new implications of therapy", Blood, 82, 15–21.
   PubMed Web of Science ®Google Scholar
• Schena, M., Larsson, L.G., Gottardi, D., Gaidano, G., Carsson, M., Nilsson, K., et al. (1992) "Growth and differentiation-associated of BCL-2 in B-chronic lymphocytic leukemia cells", Blood, 79, 2981 — 2989.
   Google Scholar
• Vawc, DL., Cory, S. and Adams, J.M. (1988) "Bc1-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells", Nature, 335, 440–442.
   Web of Science ®Google Scholar
• Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B. and Costa, J. (1992) "Induction of apotosis by wild-type p53 in a human colon tumor-derived cell line", Proc. Natl. Acad. Sci. USA, 89, 4495 — 4499.
   PubMed Web of Science ®Google Scholar
• Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, ML., Cavanee, W. and Vogelstein, B. (1992) "Clonal expansion of p53 mutant cells is associated with brain tumour progression", Nature, 355, 846 — 847.
   Google Scholar
• Makower, D., Malik, U., Novik, Y. and Wiernik, P.H. (1999) "Therapeutic efficacy of theophylline in chronic lymphocytic leukemia", Med. Oncol., 16, 69–71.
   Google Scholar
• Binet, J.L., Mentz, F., Leblond, V. and Merie-Beral, H. (1995) "Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia", Leukemia, 9, 2159–2161.
   Google Scholar
• Rai, KR., Peterson, B.L., Appelbaum, FR., Koltz, J., Elias, L., Shepherd, L., et al. (2000) "Fludarabine compared with chloram-bucil as primary therapy for chronic lymphocytic leukemia", N. Engl. J. Med., 343, 1750— 1757.
   Web of Science ®Google Scholar
• Robak, T., Blonslci, J.Z., Kasznick, M., Blasinska-Morawiec, M., Krykowslci, E., Dmoszynska, A., et al. (2000) "Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective rando-mized, mutlicenter trial", Blood, 96, 2723–2729.
   PubMed Web of Science ®Google Scholar
• Leporrier, M., Chevret, S., Cazin, B., Boujerra, N., Feugier, P., Desabien, B., et al. (2001) "Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients", Blood, 98, 2319–2325.
   PubMed Web of Science ®Google Scholar
• Basu, S. and Mitra Basu, R. (2000) "Theophylline as a therapy for chronic lymphocytic leukemia: a case report and review of literature", Haematologica (Budap), 30, 225–227.
   Google Scholar